Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading -- Ignore unavailable to you. Want to Upgrade?

To: Jay Lyons who wrote (6388)	1/14/1999 8:47:00 PM
From: Vic	Respond to of 43080

I've been following POSS for about two years. In July the company sold Series A Debentures. This depressed the price a bit, causing the drop to the $4-5 range. The low price put pressure on the shorts, causing a blow-off. But the price rise from the blow-off wasn't sustained because of the pending maturity of the debentures. After the spike, there was a 50% correction followed by a slight move upward in anticipation of the debenture maturity date (which actually happened last week.) The shorts still haven't covered yet, which makes the stock ripe for another blow-off. But what's really exciting is that we should hear nothing but good news from here out. Especially, FDA approval of the AngioJet (which the FDA has put on the fast-track). Earnings come out Feb 16. What I'm looking for at that time is an increase in sales even though they'll still be operating at a loss (growth costs money). I'm looking for positive earnings beginning with the next earnings report. In all the time I've been studying this stock, I have never heard a single negative statement about their products. Some of their old staff has retired, which is a plus and they are aggressively hiring replacements. I do feel the company needs to be more aggressive in seeking exposure -- especially on the NET. Within the next 6 months, I expect the stock to reach $15. Next year, I'm looking for it to reach the $40's. Like I said this morning, once the price passes the $10 mark, it should attract analyst coverage -- which should give it an added boost. In watching the stock movement, I have detected an indication that the shorts are keeping downward pressure, but I think a drop to the $5 level is unlikely.